pharmaceuticals-and-healthcare

Europe Biosimilars Market 2016 Industry, Analysis, Research, Share, Growth, Sales, Trends, Supply, Forecast to 2021


Published On : Feb 2016

Category : Biotechnology

No. of Pages : 133 pages

  • $3600
  • $7200

Please click below to avail discount on this report

The Europe Biosimilars Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Biosimilars industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Biosimilars market analysis is provided for the Europe markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on Europe major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Biosimilars industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 149 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

A massive portion of the overall impetus that players and markets associated with biotechnology are receiving, comes from the rapidly increasing government support. Developed economies are especially ahead of the game in terms of research and development, as well as the incorporation of ready products into the commercial markets. However, it should be noted that the average time to market for a standard biotechnology product is exceedingly higher than conventional medical products. Despite this, players are becoming ever ready to tackle the more promising fields in biotechnology, namely stem cell technology, nanotechnology, and genetic cloning. This field is poised to be an inseparable part of the healthcare industry, and is in need of heavy efforts on the research and development side.

The Europe biosimilars industry 2016 market research report is a very different market loaded with exceptional competitors and very specific customer and end user appeals. The improvement of innovations is additionally in high demand, with the developed economies demonstrating a more prominent consideration in the advancement of cutting edge advances than the developing economies. The report considers every such element while surveying the upcoming expected openings for players in the market over the coming years. It therefore converts the data presented into a matter of point of view, and offers the most ideal one for the market as far as getting favored by the key drivers and patterns influencing the market is concerned, while evading the hindrances that could prevent the advance of the players. The establishment for this investigation is made by getting the readers of this report familiar with the basic syntax of the market as it is important to completely comprehend its progression that the said entities are expected to promote themselves on.

The regional examination of the Europe biosimilars industry 2016 market research report can be depicted as a widely inclusive survey of the key locations, from the points of view of these locations as specified through their existing player base and the general end user reports for them. This is a doubly useful approach in market examination for the regional companies, as it helps them see precisely what their field of operation needs, as far as their end users are concerned. Moreover, investors will be able to figure out which organization they can pay special attention to when attempting to extend their investments profiles. Additionally, the level of detail with which every segment and region is depicted can build this report up to be a convenient guide for them with regards to enhancing their place in a particular region or country, or with regards to entering new market fruitfully over the coming years.

The competitive analysis presented in the report on the Europe biosimilars industry 2016 market research report can be an imperative device in the overall arsenal that a market player possesses. A careful learning and understanding of the competitive profiles and the contentions between players is a crucial bit of data needed by all market players, and it is the thing that this report gives to every client. The level of customization for every player takes into consideration an extraordinary standpoint for them, taking into account significantly more noteworthy data.

Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Biosimilars
1.2 Classification of Biosimilars
1.3 Applications of Biosimilars
1.4 Industry Chain Structure of Biosimilars
1.5 Industry Overview of Biosimilars
1.6 Industry Policy Analysis of Biosimilars
1.7 Industry News Analysis of Biosimilars

2 Manufacturing Cost Structure Analysis of Biosimilars
2.1 Bill of Materials (BOM) of Biosimilars
2.2 BOM Price Analysis of Biosimilars
2.3 Labor Cost Analysis of Biosimilars
2.4 Depreciation Cost Analysis of Biosimilars
2.5 Manufacturing Cost Structure Analysis of Biosimilars
2.6 Manufacturing Process Analysis of Biosimilars
2.7 Europe Price, Cost and Gross of Biosimilars 2011-2016

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of Europe Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Europe Key Biosimilars Manufacturers in 2015
3.3 R&D Status and Technology Source of Europe Biosimilars Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Europe Biosimilars Key Manufacturers in 2015

4 Production Analysis of Biosimilars by Regions, Type, and Applications
4.1 Europe Production of Biosimilars by Regions 2011-2016
4.2 Europe Production of Biosimilars by Type 2011-2016
4.3 Europe Sales of Biosimilars by Applications 2011-2016
4.4 Price Analysis of Europe Biosimilars Key Manufacturers in 2015
4.5 Europe Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Biosimilars 2011-2016

5 Consumption Volume and Consumption Value Analysis of Biosimilars by Regions
5.1 Europe Consumption Volume of Biosimilars by Regions 2011-2016
5.2 Europe Consumption Value of Biosimilars by Regions 2011-2016
5.3 Europe Consumption Price Analysis of Biosimilars by Regions 2011-2016

6 Analysis of Biosimilars Production, Supply, Sales and Market Status 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Biosimilars 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Biosimilars 2014-2015
6.3 Sales Overview of Biosimilars 2011-2016
6.4 Supply, Consumption and Gap of Biosimilars 2011-2016
6.5 Import, Export and Consumption of Biosimilars 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Biosimilars 2011-2016

7 Analysis of Biosimilars Industry Key Manufacturers
7.1 SANDOZ (Novartis)
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 SANDOZ (Novartis) SWOT Analysis

7.2 Teva Pharmaceutical
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Teva Pharmaceutical SWOT Analysis

7.3 Hospira (Pfizer)
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Hospira (Pfizer) SWOT Analysis

7.4 MYLAN
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 MYLAN SWOT Analysis

7.5 3sbio
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 3sbio SWOT Analysis

7.6 Changchun High Tech
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 Changchun High Tech SWOT Analysis

7.7 CP Guojian Pharmacy
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 CP Guojian Pharmacy SWOT Analysis

7.8 Biotech Pharma
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 Biotech Pharma SWOT Analysis

7.9 Gelgen Biopharma
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 Gelgen Biopharma SWOT Analysis

8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Biosimilars Product Types
8.5 Market Share Analysis of Different Biosimilars Price Levels
8.6 Gross Margin Analysis of Different Biosimilars Applications

9 Marketing Trader or Distributor Analysis of Biosimilars
9.1 Marketing Channels Status of Biosimilars
9.2 Traders or Distributors of Biosimilars with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Biosimilars
9.4 Europe Import, Export and Trade Analysis of Biosimilars

10 Development Trend of Biosimilars Industry 2016-2021
10.1 Capacity and Production Overview of Biosimilars 2016-2021
10.2 Production Market Share by Product Types of Biosimilars 2016-2021
10.3 Sales and Sales Revenue Overview of Biosimilars 2016-2021
10.4 Europe Sales of Biosimilars by Applications 2016-2021
10.5 Import, Export and Consumption of Biosimilars 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Biosimilars 2016-2021

11 Industry Chain Suppliers of Biosimilars with Contact Information
11.1 Major Raw Materials Suppliers of Biosimilars with Contact Information
11.2 Manufacturing Equipment Suppliers of Biosimilars with Contact Information
11.3 Major Players of Biosimilars with Contact Information
11.4 Key Consumers of Biosimilars with Contact Information
11.5 Supply Chain Relationship Analysis of Biosimilars

12 New Project Investment Feasibility Analysis of Biosimilars
12.1 New Project SWOT Analysis of Biosimilars
12.2 New Project Investment Feasibility Analysis of Biosimilars

13 Conclusion of the Europe Biosimilars Industry 2016 Market Research Report

Figure Picture of Biosimilars
Table Product Specifications of Biosimilars
Table Classification of Biosimilars
Figure Europe Sales Market Share of Biosimilars by Product Types in 2015
Table Applications of Biosimilars
Figure Europe Sales Market Share of Biosimilars by Applications in 2015
Figure Industry Chain Structure of Biosimilars
Table Europe Industry Overview of Biosimilars
Table Industry Policy of Biosimilars
Table Industry News List of Biosimilars
Table Bill of Materials (BOM) of Biosimilars
Table Bill of Materials (BOM) Price of Biosimilars
Table Labor Cost of Biosimilars
Table Depreciation Cost of Biosimilars
Table Manufacturing Cost Structure Analysis of Biosimilars in 2015
Figure Manufacturing Process Analysis of Biosimilars
Table Europe Price Analysis of Biosimilars 2011-2016 (USD/Unit)
Table Europe Cost Analysis of Biosimilars 2011-2016 (USD/Unit)
Table Europe Gross Analysis of Biosimilars 2011-2016
Table Capacity (K Units) and Commercial Production Date of Europe Biosimilars Key Manufacturers in 2015
Table Manufacturing Plants Distribution of Europe Key Biosimilars Manufacturers in 2015
Table R&D Status and Technology Source of Europe Biosimilars Key Manufacturers in 2015
Table Raw Materials Sources Analysis of Europe and Europe Biosimilars Key Manufacturers in 2015
Table Europe Production of Biosimilars by Regions 2011-2016 (K Units)
Table Europe Production Market Share of Biosimilars by Regions 2011-2016
Figure Europe Production Market Share of Biosimilars by Regions in 2014
Figure Europe Production Market Share of Biosimilars by Regions in 2015
Table Europe Production of Biosimilars by Types in 2011-2016 (K Units)
Table Europe Production Market Share of Biosimilars by Type in 2011-2016
Figure Europe Production Market Share of Biosimilars by Type in 2014
Figure Europe Production Market Share of Biosimilars by Type in 2015
Table Europe Sales of Biosimilars by Applications 2011-2016 (K Units)
Table Europe Production Market Share of Biosimilars by Applications 2011-2016
Figure Europe Production Market Share of Biosimilars by Applications in 2014
Figure Europe Production Market Share of Biosimilars by Applications in 2015
Table Price Comparison of Europe Biosimilars Key Manufacturers in 2015 (USD/Unit)
Table Europe Capacity, Production, Import Export Sales Price , Cost  and Revenue (M USD) of Biosimilars 2011-2016
Table Europe Consumption Volume of Biosimilars by Regions 2011-2016 (K Units)
Table Europe Consumption Volume Market Share of Biosimilars by Regions 2011-2016
Figure Europe Consumption Volume Market Share of Biosimilars by Regions in 2014
Figure Europe Consumption Volume Market Share of Biosimilars by Regions in 2015
Table Europe Consumption Value of Biosimilars by Regions 2011-2016 (M USD)
Table Europe Consumption Value Market Share of Biosimilars by Regions 2011-2016
Figure Europe Consumption Value Market Share of Biosimilars by Regions in 2014
Figure Europe Consumption Value Market Share of Biosimilars by Regions in 2015
Table Consumption Price of Biosimilars by Regions 2011-2016 (USD/Unit)
Table Europe and Major Manufacturers Capacity of Biosimilars 2011-2016 (K Units)
Table Europe Capacity Market Share of Major Biosimilars Manufacturers 2011-2016
Table Europe and Major Manufacturers Production of Biosimilars 2011-2016 (K Units)
Table Europe Production Market Share of Major Biosimilars Manufacturers 2011-2016
Table Europe and Major Manufacturers Sales of Biosimilars 2011-2016 (K Units)
Table Europe Sales Market Share of Major Biosimilars Manufacturers 2011-2016
Table Europe and Major Manufacturers Sales Revenue of Biosimilars 2011-2016 (M USD)
Table Europe Sales Revenue Market Share of Major Biosimilars Manufacturers 2011-2016
Figure Europe Capacity (K Units), Production (K Units) and Growth Rate of Biosimilars 2011-2016
Figure Europe Capacity Utilization Rate of Biosimilars 2011-2016
Figure Europe Sales Revenue (M USD) and Growth Rate of Biosimilars 2011-2016
Figure Europe Production Market Share of Major Biosimilars Manufacturers in 2014
Figure Europe Production Market Share of Major Biosimilars Manufacturers in 2015
Figure Europe Sales Market Share of Major Biosimilars Manufacturers in 2014
Figure Europe Sales Market Share of Major Biosimilars Manufacturers in 2015
Figure Europe Sales (K Units) and Growth Rate of Biosimilars 2011-2016
Table Europe Supply, Consumption and Gap of Biosimilars 2011-2016 (K Units)
Table Europe Import, Export and Consumption of Biosimilars 2011-2016 (K Units)
Table Price of Europe Biosimilars Major Manufacturers 2011-2016 (USD/Unit)
Table Gross Margin of Europe Biosimilars Major Manufacturers 2011-2016
Table Europe and Major Manufacturers Revenue of Biosimilars 2011-2016 (M USD)
Table Europe Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Biosimilars 2011-2016
Table SANDOZ (Novartis) Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilars Picture and Specifications of SANDOZ (Novartis)
Table Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of SANDOZ (Novartis) 2011-2016
Figure Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of SANDOZ (Novartis) 2011-2016
Figure Biosimilars Production (K Units) and Europe Market Share of SANDOZ (Novartis) 2011-2016
Table SANDOZ (Novartis) Biosimilars SWOT Analysis
Table Teva Pharmaceutical Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilars Picture and Specifications of Teva Pharmaceutical
Table Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Teva Pharmaceutical 2011-2016
Figure Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Teva Pharmaceutical 2011-2016
Figure Biosimilars Production (K Units) and Europe Market Share of Teva Pharmaceutical 2011-2016
Table Teva Pharmaceutical Biosimilars SWOT Analysis
Table Hospira (Pfizer) Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilars Picture and Specifications of Hospira (Pfizer)
Table Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Hospira (Pfizer) 2011-2016
Figure Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Hospira (Pfizer) 2011-2016
Figure Biosimilars Production (K Units) and Europe Market Share of Hospira (Pfizer) 2011-2016
Table Hospira (Pfizer) Biosimilars SWOT Analysis
Table MYLAN Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilars Picture and Specifications of MYLAN
Table Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of MYLAN 2011-2016
Figure Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of MYLAN 2011-2016
Figure Biosimilars Production (K Units) and Europe Market Share of MYLAN 2011-2016
Table MYLAN Biosimilars SWOT Analysis
Table 3sbio Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilars Picture and Specifications of 3sbio
Table Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of 3sbio 2011-2016
Figure Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of 3sbio 2011-2016
Figure Biosimilars Production (K Units) and Europe Market Share of 3sbio 2011-2016
Table 3sbio Biosimilars SWOT Analysis
Table Changchun High Tech Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilars Picture and Specifications of Changchun High Tech
Table Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Changchun High Tech 2011-2016
Figure Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Changchun High Tech 2011-2016
Figure Biosimilars Production (K Units) and Europe Market Share of Changchun High Tech 2011-2016
Table Changchun High Tech Biosimilars SWOT Analysis
Table CP Guojian Pharmacy Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilars Picture and Specifications of CP Guojian Pharmacy
Table Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of CP Guojian Pharmacy 2011-2016
Figure Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of CP Guojian Pharmacy 2011-2016
Figure Biosimilars Production (K Units) and Europe Market Share of CP Guojian Pharmacy 2011-2016
Table CP Guojian Pharmacy Biosimilars SWOT Analysis
Table Biotech Pharma Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilars Picture and Specifications of Biotech Pharma
Table Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Biotech Pharma 2011-2016
Figure Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Biotech Pharma 2011-2016
Figure Biosimilars Production (K Units) and Europe Market Share of Biotech Pharma 2011-2016
Table Biotech Pharma Biosimilars SWOT Analysis
Table Gelgen Biopharma Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilars Picture and Specifications of Gelgen Biopharma
Table Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Gelgen Biopharma 2011-2016
Figure Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Gelgen Biopharma 2011-2016
Figure Biosimilars Production (K Units) and Europe Market Share of Gelgen Biopharma 2011-2016
Table Gelgen Biopharma Biosimilars SWOT Analysis
Table Biosimilars Price by Regions 2011-2016
Table Biosimilars Price by Product Types 2011-2016
Table Biosimilars Price by Companies 2011-2016
Table Biosimilars Gross Margin by Companies 2011-2016
Table Price Comparison of Biosimilars by Regions 2011-2016 (USD/Unit)
Table Price of Different Biosimilars Product Types (USD/Unit)
Table Market Share of Different Biosimilars Price Level
Table Gross Margin of Different Biosimilars Applications
Table Marketing Channels Status of Biosimilars
Table Traders or Distributors of Biosimilars with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Biosimilars (USD/Unit) in 2015
Table Europe Import, Export, and Trade of Biosimilars (K Units)
Figure Europe Capacity (K Units), Production (K Units) and Growth Rate of Biosimilars 2016-2021
Figure Europe Capacity Utilization Rate of Biosimilars 2016-2021
Table Europe Biosimilars Production by Type 2016-2021 (K Units)
Table Europe Biosimilars Production Market Share by Type 2016-2021
Figure Europe Production Market Share of Biosimilars by Type in 2021
Figure Europe Sales (K Units) and Growth Rate of Biosimilars 2016-2021
Figure Europe Sales Revenue (Million USD) and Growth Rate of Biosimilars 2016-2021
Figure Europe Sales of Biosimilars by Applications 2016-2021 (K Units)
Table Europe Production Market Share of Biosimilars by Applications 2016-2021
Figure Europe Production Market Share of Biosimilars by Applications in 2021
Table Europe Production, Import, Export and Consumption of Biosimilars 2016-2021 (K Units)
Table Europe Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Biosimilars 2016-2021
Table Major Raw Materials Suppliers of Biosimilars with Contact Information
Table Manufacturing Equipment Suppliers of Biosimilars with Contact Information
Table Major Players of Biosimilars with Contact Information
Table Key Consumers of Biosimilars with Contact Information
Table Supply Chain Relationship Analysis of Biosimilars
Table New Project SWOT Analysis of Biosimilars
Table New Project Investment Feasibility Analysis of Biosimilars
Table Part of Interviewees Record List

Request a Sample Copy

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top